Search Results for "Mylan Atovaquone And Proguanil 250mg 100mg Tablet"

23:10 EDT 23rd May 2015 | BioPortfolio

Matching Channels

Pancreatic Cancer

The pancreas secretes a number of important hormones into the digestive tract and the blood stream. Cancers are most commonly exocrine than endocrine (neuroendocrine) tumors. Functional tumors secre...

Selective monoamine oxidase type B MAOB inhibitors

The clinical benefit of monoamine oxidase type B (MAO-B) inhibitors is thought to arise from an ability of these medications to enhance the level of dopamine by decreasing the catabolism. Additional...

Matching News

Mylan introduces Lamivudine Tablets, 100mg to treat hepatitis B virus

US-based pharmaceutical firm Mylan has introduced its Lamivudine Tablets, 100mg, which is the generic version of GlaxoSmithKline's Epivir-HBV.

Gilead and Mylan expand Sovaldi pact

Mylan Laboratories is expanding its hepatitis C licensing agreement with Gilead Sciences to include the non-exclusive rights to manufacture and distribute the investigational NS5A inhibitor GS-5816 an...

Otsuka Pharmaceutical to Launch L-Cartin FF Tablets for Carnitine Deficiencies in Japan

On December 5, Otsuka Pharmaceutical is launching a new form of L-Cartin, L-Cartin Free Form (FF) tablets (generic name levocarnatine) in two doses, 100mg and 250mg.

Chloroquine sulphate syrup has been discontinued

Chloroquine sulphate syrup (Nivaquine; Sanofi) has been discontinued and will no longer be marketed in the UK. The expiry date for the last batch supplied is March 2015. Other chloroquine phosphate sy...

Malaria: when an antimalarial drug is no longer fit for purpose

High fever, chills, cramps and severe anaemia are typical symptoms of malaria, even its mild form. According to World Health Organisation (WHO) estimates, around 660,000 people die from malaria every ...

Mylan Signs Deal With Gilead To Enhance Access To TAF-based HIV Treatments

CANONSBURG (dpa-AFX) - Mylan Inc. (MYL) announced that its subsidiary Mylan Laboratories Limited has entered into an agreement with Gilead Sciences Inc. (GILD) under which Mylan has licensed the n...

UPDATE 4-Perrigo rejects raised Mylan bid; Teva recommits to Mylan buy

* Teva responds to Mylan rejection (Adds details from Teva letter to Mylan, updates shares)

Mylan Settles Patent Litigation With Pfizer On Viagra

CANONSBURG (dpa-AFX) - Mylan N.V. (MYL) announced that its subsidiaries Mylan Inc. and Mylan Pharmaceuticals Inc. reached a settlement and license agreement with Pfizer Inc. (PFE), Pfizer Limited ...

Matching PubMed Articles

Novel Mutation in Cytochrome B of Plasmodium falciparum in One of Two Atovaquone-Proguanil Treatment Failures in Travelers Returning From Same Site in Nigeria.

Atovaquone-proguanil (AP) is the most commonly used treatment for uncomplicated Plasmodium falciparum malaria in the United States. Apparent AP treatment failures were reported 7 months apart in 2 Ame...

Effects of d-penicillamine on pentylenetetrazole-induced seizures in mice: Involvement of nitric oxide/NMDA pathways.

Besides the clinical applications of penicillamine, some reports show that use of d-penicillamine (d-pen) has been associated with adverse effects such as seizures. So, the purpose of this study was t...

Effectiveness of antiretroviral therapy in individuals who for economic reasons were switched from a once-daily single-tablet regimen to a triple-tablet regimen.

To assess the impact on virological outcomes of a switch from branded single-tablet regimen (STR) including tenofovir, efavirenz, and emtricitabine (STR-TEE) to generic triple-tablet regimen (TTR), in...

Pharmacological rational of dry ripe fruit of Aegle marmelos L. as an anti-nociceptive agent in different painful conditions.

The aim of study is to investigate central and peripheral analgesic effects of methanolic extract of dry ripe fruit of Aegle marmelos Linn. Corea (Am. Cr) by two methods, tail flick test and acetic ac...

Estimation of Young's modulus of pharmaceutical tablet obtained by terahertz time-delay measurement.

In this paper, it is suggested that Young's modulus of pharmaceutical tablets with different porosity can be estimated from terahertz (THz) pulse time delay. We demonstrate such a possibility using a ...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement